BRIEF published on 02/06/2026 at 07:35, 1 month 13 days ago Sensorion participera à la 49e réunion annuelle d'hiver de l'ARO. Biotechnologie Thérapie Génique Sensorion Perte Auditive Réunion ARO
BRIEF published on 02/06/2026 at 07:35, 1 month 13 days ago Sensorion to Participate in ARO 49th Annual Midwinter Meeting Biotechnology Gene Therapy Sensorion Hearing Loss ARO Meeting
PRESS RELEASE published on 02/06/2026 at 07:30, 1 month 13 days ago Informations privilégiées / Autres communiqués Sensorion participe à la 49ème rencontre annuelle de l’ARO pour présenter sa nouvelle thérapie génique SENS-601 pour la surdité autosomique récessive non syndromique 1A Thérapie Génique Sensorion Perte Auditive Surdité ARO
PRESS RELEASE published on 02/06/2026 at 07:30, 1 month 13 days ago Inside Information / Other news releases Sensorion to present SENS-601 gene therapy at ARO 49th Annual Midwinter Meeting in Puerto Rico Gene Therapy Sensorion Hearing Loss SENS-601 ARO 49th Annual Midwinter Meeting
BRIEF published on 01/28/2026 at 07:48, 1 month 22 days ago Sensorion Secures €60 Million Financing to Advance Hearing Loss Therapies Gene Therapy Biotech Financing Sensorion Hearing Loss Sanofi Investment
BRIEF published on 01/28/2026 at 07:48, 1 month 22 days ago Sensorion obtient un financement de 60 millions d'euros pour faire progresser les thérapies contre la perte auditive Thérapie Génique Sensorion Perte Auditive Financement Des Biotechnologies Investissements Sanofi
PRESS RELEASE published on 01/28/2026 at 07:43, 1 month 22 days ago Inside Information / Other news releases Sensorion announces €60 million financing with a €20M strategic investment from Sanofi and support from global healthcare specialists to advance genetic medicine pipeline. Cash runway extended until H1 2027 Financing Sanofi Sensorion Genetic Medicine Healthcare Specialists
PRESS RELEASE published on 01/28/2026 at 07:43, 1 month 22 days ago Informations privilégiées / Autres communiqués Sensorion annonce un financement de 60 millions d’euros avec Sanofi et d'autres investisseurs pour développer ses thérapies géniques. Trésorerie prévue jusqu'à mi-2027 Financement Trésorerie Thérapie Génique Sanofi Sensorion
BRIEF published on 12/19/2025 at 07:35, 3 months ago Sensorion présentera ses services lors de la conférence JP Morgan Healthcare. Biotechnologie Thérapie Génique JP Morgan Perte Auditive SENS-401
BRIEF published on 12/19/2025 at 07:35, 3 months ago Sensorion to Present at J.P. Morgan Healthcare Conference Biotechnology Gene Therapy J.P. Morgan Hearing Loss SENS-401
Published on 03/19/2026 at 21:16, 2 hours 39 minutes ago Unusual Machines, Inc. Announces Proposed Public Offering
Published on 03/19/2026 at 14:20, 9 hours 35 minutes ago CBMJ CEO Rips Legacy Liberal Media Over Iran Coverage on The Schaftlein Report
Published on 03/19/2026 at 13:50, 10 hours 5 minutes ago Predictiv AI Appoints Multi-Agent Systems Pioneer Professor George Rzevski as Strategic Advisor to Advance Swarm AI Platforms
Published on 03/19/2026 at 13:30, 10 hours 25 minutes ago Hillcrest Energy Technologies CEO Don Currie Discusses ZVS Technology and Commercialization Progress in Stocks To Watch Investor Interview
Published on 03/19/2026 at 13:30, 10 hours 25 minutes ago ACCESS Newswire Reports Fourth Quarter and Full Year 2025 Results
Published on 03/19/2026 at 23:48, 6 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C daily buy back notice
Published on 03/19/2026 at 22:55, 59 minutes ago Baristas behind millions of cups of coffee compete globally
Published on 03/19/2026 at 22:48, 1 hour 6 minutes ago EQS-Adhoc: Forecast for the 2026 financial year
Published on 03/19/2026 at 19:24, 4 hours 30 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/19/2026 at 18:00, 5 hours 55 minutes ago Filing of the 2025 Universal Registration Document
Published on 03/19/2026 at 18:00, 5 hours 55 minutes ago Mise à disposition du Document d’Enregistrement Universel 2025
Published on 03/19/2026 at 08:45, 15 hours 10 minutes ago Deezer et Sonos renouvellent et étendent leur partenariat stratégique
